Management of primary endomyocardial disease. The myocarditis-endocardial fibroelastosis syndrome.
D000219:Adams-Stokes Syndrome / Q000628:therapy; D000367:Age Factors; D001145:Arrhythmias, Cardiac / Q000628:therapy; D006332:Cardiomegaly / Q000628:therapy; D009202:Cardiomyopathies / Q000628:therapy*; D002312:Cardiomyopathy, Hypertrophic / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003327:Coronary Disease / Q000628:therapy; D003330:Coronary Vessel Anomalies; D004562:Electrocardiography; D004695:Endocardial Fibroelastosis / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D004719:Endomyocardial Fibrosis / Q000628:therapy; D006327:Heart Block / Q000628:therapy; D006329:Heart Conduction System / Q000503:physiopathology; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000628:therapy; D007049:Iatrogenic Disease / Q000628:therapy; D007223:Infant; D009203:Myocardial Infarction / Q000628:therapy; D009205:Myocarditis / Q000145:classification / Q000150:complications / Q000628:therapy*; D011379:Prognosis; D011859:Radiography; D014927:Wolff-Parkinson-White Syndrome / Q000628:therapy